EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species

TagContent
EnhancerAtlas ID
HS023-16277 
Organism
Homo sapiens 
Tissue/cell
CD8+ 
Coordinate
chr20:48416430-48418190 
TF binding sites/motifs
Number: 6             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
FOSL2MA0478.1chr20:48417366-48417377ATGAGTCATCC-6.62
JUN(var.2)MA0489.1chr20:48416562-48416576GTGAGTCATTCCCT-6.31
JUN(var.2)MA0489.1chr20:48417366-48417380ATGAGTCATCCTTT-7.08
JUNBMA0490.1chr20:48417366-48417377ATGAGTCATCC-6.62
ZNF263MA0528.1chr20:48416591-48416612AGAGGAGAGGGTGAAGAAGGA+6.18
ZfxMA0146.2chr20:48417968-48417982GAGGCCGAGGCGGG-6.01
Number of super-enhancer constituents: 5             
IDCoordinateTissue/cell
SE_10052chr20:48416546-48417962CD14
SE_53571chr20:48416214-48416892Spleen
SE_53571chr20:48417110-48418014Spleen
SE_59121chr20:48392206-48441118Ly3
SE_60900chr20:48401596-48463292DHL6
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 3             
ChromosomeStartEnd
chr204841727848417603
chr204841719548417606
chr204841688048416976
Number: 2             
IDChromosomeStartEnd
GH20I049801chr204841688048416976
GH20I049800chr204841713848417937
Enhancer Sequence
ATCTGCTTTG ACCTTTGAGA CGAATGCATG GAGATCTATT GATCGGATGG GCCACGTTTG 60
TTTCCCACAC TTCGTTGAAA AATTGGGGGT GAAAAAAACT GGGAGTGAAA AAATGGCCAA 120
ACCAAAAGAA GGGTGAGTCA TTCCCTCCTA CCCCAAAATA CAGAGGAGAG GGTGAAGAAG 180
GAGGACCGCC CCTCCTCGCT CCAGTAAAGC CTTTAACAGG CCCATCCTGA TTTACAGGGA 240
GCGGACTTGG TTTCCTGTTC AAGAATTTCC AAGGCAAAAA CAATCCTCAA ACACATGAAG 300
ATGAGGTTGG GCAAATAACT CATGGATGGT CTCAACGCTG GAGGGCAAAG TTGTTTATTA 360
AGCTCCCGAC CCTCAAAGGG AATTACTTAA ATTTTTTTCT TGATTATAAA AGTAGTATTC 420
CAGCCTGGGC AACAAGAGCG AGACTCCATC TCAAAAAAAA AAAAAAAAAA AAAAAGTATT 480
GGCTCATCAC TATGAAAAAG CATTTTCAGA GAATACAGAA AAGTGTGAGG AATAGAATAA 540
AAAACAGTCA TAATTTTGGA GCATTTTGTA AGTTAGCCCA TAGATTTTTT AAATGCATAC 600
ACATGTACTT AATTCTAAAG TGAACCTGTG CTATCTTTTT ATTTAACAGT AATCCTAAGA 660
TTTATTGAGT ATGTACAATG CATATGCTAG TTGCTCTCTG TGTATTAATC CATTTTATAT 720
TTACAGTAGT CCTGTGTGAT AAGCACTATT ATTAATTCAA TTTTATAGAT GGGGAAACTG 780
AGGCAGAGAG CAGTTAAGTG ATTTACCCAA GATCACACAA GGTGGCCAAG CTGGAATTCA 840
GAAACAAGTA ATCTGGCTTC AAGGCCCATG ACGTTAACCA CTATACTACA TTGCTAAGGC 900
AGAGCAGAGA CCCCTCCCAA GTTAATACCC ATAGATATGA GTCATCCTTT TTAGTGCCTG 960
CACTTATTCT TCTATTACTA GATAATTGGG CTTTTTCTAG TTTCCCCCTA CTAGGAAATA 1020
GAGAGAAACT TCCCTTTTGG GCTTTAAATT AGACAAGAAA ATATGCGGTT AGATGTCACC 1080
ACAACTTGTA CTTCTTTTTT TTTTTTTTTT TTTTGAGACA GGGCTCGCTC TGTCACCCAG 1140
GCTGGAGTGC AGTGGTGCGA TCACAGCTCA CTGCAGCTTT GACCTCCCAG GCTCAATCTA 1200
TTCTCCCGCC TCAATCTATT CTCCCACTTC AGCCTTCTGA GTAGTTGGGA CTACAAGTGC 1260
ACACCACCGT GCCTGACTAT TTATTTCTCT TTTCTGTAGA CATGGGGTCT CACTGTGTTG 1320
CCCAGGCTAA CAACTGGTAT TTCTAACCCA GGAGAAGCAA CGAAGGGCTC AGCCCTACTT 1380
TGAAGCAATC GCCCCATTAT GCACATATAT ATTGACTGGG GGAGGTTATT TTATTTAAGA 1440
AACATCCATG AAGTACTTAT GTGCCAGACA GACATGGCTT CAAGAACTTC TGAATAGGCT 1500
GGGCACGGTG GCTCACGCCT GTAATCCCAA CACTTTGGGA GGCCGAGGCG GGCGGATCAC 1560
GAGGTCAGGA ATTCGAGACC AGCCTGGCCA ACATGGTGAA ACCCCGTCTC TACTAAAAAT 1620
ACAAAAACTT AGCTGGGCGT GGTGGTGGGC GCCTGTAATT CCAGCTACTT GGGAGGCTGA 1680
GGCAGGAGAA TTGCTTGAAC CCAGGAGGCA GAGGTTGCAG TGCAGTGATC CGAGGTCACG 1740
CCATTGCACT CCAGCCTGGG 1760